QuantaMatrix Inc. (KOSDAQ:317690)
3,130.00
-10.00 (-0.32%)
At close: May 29, 2026
QuantaMatrix Revenue
QuantaMatrix had revenue of 725.67M KRW in the quarter ending March 31, 2026, a decrease of -28.69%. This brings the company's revenue in the last twelve months to 3.40B, up 24.58% year-over-year. In the year 2025, QuantaMatrix had annual revenue of 3.69B with 47.70% growth.
Revenue (ttm)
3.40B
Revenue Growth
+24.58%
P/S Ratio
18.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.69B | 1.19B | 47.70% |
| Dec 31, 2024 | 2.50B | -620.82M | -19.91% |
| Dec 31, 2023 | 3.12B | 1.83B | 142.47% |
| Dec 31, 2022 | 1.29B | 736.16M | 133.90% |
| Dec 31, 2021 | 549.77M | -1.14B | -67.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.27B |
| DRGEM | 106.74B |
| JPI Healthcare | 47.97B |
| L&K Biomed | 39.53B |
| Hironic | 34.19B |
| SELVAS Healthcare | 30.19B |
| Remed | 25.24B |
| Dynamic solution | 15.46B |